Steward Partners Investment Advisory’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78K | Hold |
100
| – | – | ﹤0.01% | 3761 |
|
|
2025
Q1 | $1.78K | Sell |
100
-349
| -78% | -$6.22K | ﹤0.01% | 3669 |
|
|
2024
Q4 | $13.4K | Sell |
449
-50
| -10% | -$1.49K | ﹤0.01% | 2973 |
|
|
2024
Q3 | $7.8K | Sell |
499
-250
| -33% | -$3.91K | ﹤0.01% | 3045 |
|
|
2024
Q2 | $12.8K | Buy |
749
+40
| +6% | +$685 | ﹤0.01% | 2718 |
|
|
2024
Q1 | $11.1K | Hold |
709
| – | – | ﹤0.01% | 2768 |
|
|
2023
Q4 | $10.6K | Hold |
709
| – | – | ﹤0.01% | 2682 |
|
|
2023
Q3 | $11.5K | Sell |
709
-100
| -12% | -$1.62K | ﹤0.01% | 2543 |
|
|
2023
Q2 | $33.6K | Hold |
809
| – | – | ﹤0.01% | 2050 |
|
|
2023
Q1 | $48.7K | Hold |
809
| – | – | ﹤0.01% | 1873 |
|
|
2022
Q4 | $59.3K | Hold |
809
| – | – | ﹤0.01% | 1766 |
|
|
2022
Q3 | $61K | Sell |
809
-30
| -4% | -$2.26K | ﹤0.01% | 1701 |
|
|
2022
Q2 | $58K | Sell |
839
-20
| -2% | -$1.38K | ﹤0.01% | 1731 |
|
|
2022
Q1 | $71K | Hold |
859
| – | – | ﹤0.01% | 1749 |
|
|
2021
Q4 | $64K | Sell |
859
-220
| -20% | -$16.4K | ﹤0.01% | 1785 |
|
|
2021
Q3 | $125K | Sell |
1,079
-40
| -4% | -$4.63K | ﹤0.01% | 1460 |
|
|
2021
Q2 | $248K | Sell |
1,119
-75
| -6% | -$16.6K | ﹤0.01% | 1401 |
|
|
2021
Q1 | $158K | Sell |
1,194
-70
| -6% | -$9.25K | ﹤0.01% | 1402 |
|
|
2020
Q4 | $219K | Buy |
1,264
+1,064
| +532% | +$184K | ﹤0.01% | 1036 |
|
|
2020
Q3 | $22K | Hold |
200
| – | – | ﹤0.01% | 1861 |
|
|
2020
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 1968 |
|
|
2020
Q1 | $13K | Hold |
200
| – | – | ﹤0.01% | 1761 |
|
|
2019
Q4 | $16K | Hold |
200
| – | – | ﹤0.01% | 1838 |
|
|
2019
Q3 | $14K | Buy |
+200
| New | +$14K | ﹤0.01% | 1852 |
|